These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 6418079)
1. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients]. Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079 [TBL] [Abstract][Full Text] [Related]
2. [UFT concentration in various tissues from cancer patients]. Kasai Y; Nakanishi Y; Nishi H; Nishindai H; Yoshimoto M; Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E Gan To Kagaku Ryoho; 1983 Oct; 10(10):2130-8. PubMed ID: 6414381 [TBL] [Abstract][Full Text] [Related]
3. [5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration]. Tanimura T; Kaneshige E; Fujiwara K; Kobashi Y; Inoue K; Kono I; Sekiba K Gan To Kagaku Ryoho; 1986 Feb; 13(2):349-55. PubMed ID: 3080967 [TBL] [Abstract][Full Text] [Related]
4. Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil. Muggia FM; Wu X; Spicer D; Groshen S; Jeffers S; Leichman CG; Leichman L; Chan KK Clin Cancer Res; 1996 Sep; 2(9):1461-7. PubMed ID: 9816321 [TBL] [Abstract][Full Text] [Related]
5. [Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT]. Kusama M; Utsunomiya Y; Ono T; Nagura H; Enomoto S Gan To Kagaku Ryoho; 1983 Aug; 10(8):1796-802. PubMed ID: 6411004 [TBL] [Abstract][Full Text] [Related]
6. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil. Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123 [TBL] [Abstract][Full Text] [Related]
7. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer. Hoff PM; Pazdur R; Benner SE; Canetta R Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235 [TBL] [Abstract][Full Text] [Related]
8. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)]. Sekiguchi I; Suzuki M; Tamada T; Nishida M Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312 [TBL] [Abstract][Full Text] [Related]
9. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT]. Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701 [TBL] [Abstract][Full Text] [Related]
10. [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration]. Suenaga M Gan To Kagaku Ryoho; 1987 Dec; 14(12):3313-8. PubMed ID: 2825604 [TBL] [Abstract][Full Text] [Related]
11. [Blood and tumor levels of tegafur, 5-fluorouracil, and uracil]. Takeshita T; Iwasaki M; Narita M; Sou M; Sato M; Hashimoto T; Kameya S; Iigima N Gan To Kagaku Ryoho; 1988 Nov; 15(11):3053-8. PubMed ID: 3142365 [TBL] [Abstract][Full Text] [Related]
12. [Comparative pharmacokinetic study between UFT and FT-207 suppo and phase II studies in gynecological malignancies]. Hatae M; Terahara M; Hokanishi H Gan To Kagaku Ryoho; 1984 Nov; 11(11):2386-92. PubMed ID: 6437345 [TBL] [Abstract][Full Text] [Related]
13. [Clinical effect of UFT on bladder cancer]. Asahi T; Matsumura Y; Ozaki Y; Yoshimoto J; Kaneshige T; Kumon H; Tsushima T; Ohmori H Gan To Kagaku Ryoho; 1982 Mar; 9(3):503-7. PubMed ID: 6820901 [TBL] [Abstract][Full Text] [Related]
14. [Effects of preoperative administration of UFT in gastrointestinal cancer]. Sato Y; Une Y; Nagabuchi E; Matsuoka S; Kagaya H; Miyata S; Yakura Y; Uchino J Gan To Kagaku Ryoho; 1986 Feb; 13(2):337-41. PubMed ID: 3080966 [TBL] [Abstract][Full Text] [Related]
15. [Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT]. Tomita T; Tajima T; Ishibashi M; Tagaya N; Aoki H; Itoh S; Kadowaki A; Kogure H; Tajima Y Gan To Kagaku Ryoho; 1989 Dec; 16(12):3755-62. PubMed ID: 2512859 [TBL] [Abstract][Full Text] [Related]
16. [5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT]. Oiwa T; Saito H Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):525-30. PubMed ID: 3082289 [TBL] [Abstract][Full Text] [Related]
17. [Concentration of 5-FU level in the tissue and blood of the patients with breast cancer by preoperative administration of UFT]. Suemasu K; Nomoto C; Higashi Y Gan To Kagaku Ryoho; 1982 Apr; 9(4):667-71. PubMed ID: 6820904 [TBL] [Abstract][Full Text] [Related]
18. [5-FU concentration in the blood and tissue of patients with gastric and colorectal cancer after administration of UFT or tegafur]. Arima S; Futami K; Shigeta M; Kinashi M; Shimura H Gan To Kagaku Ryoho; 1986 Aug; 13(8):2618-24. PubMed ID: 3090940 [TBL] [Abstract][Full Text] [Related]
19. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma. Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517 [TBL] [Abstract][Full Text] [Related]
20. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207]. Takeshita M; Ishikawa H; Seki M; Ikeya T; Miyamoto Y; Izuo M; Tozuka S; Usui R; Kaneko H Gan No Rinsho; 1985 Oct; 31(13):1697-703. PubMed ID: 3935831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]